Rising to the innovation challenge
This article was originally published in Scrip
Executive Summary
The past few weeks have seen a flurry of moves to shore up innovation in pharmaceutical and medical research in the EU. Despite the deepening economic gloom, and as member states pare public spending to the bone, governments and institutions appear to be looking beyond the immediate future with pledges on funding incentives, new innovation centres, greater use of public-private partnerships (PPPs) and the like.